Sarah Lindsay
Nurse Practitioner · Naples, FLNPI 1740483676
Payments from drug & device makers
Across 150 payments — averaging $30.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$937
- Takeda Pharmaceuticals U.S.A., Inc.$458
- E.r. Squibb & Sons, L.L.C.$254
- Phathom Pharmaceuticals, Inc.$251
- Madrigal Pharmaceuticals$207
- Inspire Medical Systems, Inc.$176
- plus $2K from 35 others
What the payments were for
- Consulting fees$190%
- Food & beverage$4,51099%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$230
- NURTEC ODT$229
- Inspire Upper Airway Stimulation System$176
- CAMZYOS$133
- REZDIFFRA$132
- QULIPTA$125
- ZEPOSIA$121
- VOQUEZNA$116
- SHINGRIX$106
How this compares
$4,541 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 19 | $60,397 |
| LinzessLinaclotide | 26 | $14,202 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 52 | $8,332 |
| Pantoprazole Sodium | 242 | $2,834 |
| Rabeprazole Sodium | 53 | $2,548 |
| Mesalamine | 11 | $2,096 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 30 | $1,957 |
| SuflavePeg 3350/Sod Sulf,chlr/Pot/Mag | 14 | $1,738 |
| CholestyramineCholestyramine (With Sugar) | 28 | $1,461 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 70 | $960 |
| Omeprazole | 65 | $567 |
| Rosuvastatin Calcium | 34 | $392 |
| Atorvastatin Calcium | 51 | $360 |
| Famotidine | 17 | $301 |
| Metoprolol Succinate | 20 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $937 | $74,59945 claims |
| Braintree Laboratories, Inc.Sutab, Suflave | $58 | $10,06966 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Naples
- Stephanie SimmermanNaples$283K
- Doreen CassarinoNaples$41K
- Tara McGaheyNaples$21K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.